Current trials of interventions to prevent radiocontrast-induced nephropathy

Arif Asif, Galo Garces, Richard A Preston, David Roth

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Radiocontrast administration is a common cause of hospital-acquired acute renal failure. It is associated with significant in-hospital and long-term morbidity and mortality and increases the costs of medical care by at least extending the hospital stay. A variety of therapeutic interventions, including saline hydration, diuretics, mannitol, calcium channel antagonists, theophylline, endothelin receptor antagonists, and dopamine, have been employed to prevent radiocontrast-induced acute renal failure. Recent advances have examined the impact of fenoldopam (dopamine-1 receptor agonist), N-acetylcysteine (antioxidant), iso-osmolar contrast agents, hemodialysis, and hemofiltration on ameliorating radiocontrast-induced acute renal failure. Although hydration with half-normal saline had remained the gold standard for the prevention of radiocontrast-induced nephropathy, recent data have revealed the superiority of hydration with normal saline over half-normal saline. This review focuses on the most recent studies of interventions to ameliorate radiocontrast-induced acute renal failure and provides a critical analysis of some of the recent studies conducted to prevent radiocontrast-induced nephropathy.

Original languageEnglish
Pages (from-to)127-132
Number of pages6
JournalAmerican Journal of Therapeutics
Volume12
Issue number2
DOIs
StatePublished - Mar 1 2005

Fingerprint

Acute Kidney Injury
Fenoldopam
Hemofiltration
Dopamine Agonists
Calcium Channel Blockers
Acetylcysteine
Mannitol
Theophylline
Diuretics
Health Care Costs
Contrast Media
Renal Dialysis
Dopamine
Length of Stay
Antioxidants
Morbidity
Mortality
Therapeutics

Keywords

  • Fenoldopam
  • Iso-osmolar contrast medium
  • N-acetylcysteine
  • Radiocontrast-induced nephropathy
  • Renal replacement therapy

ASJC Scopus subject areas

  • Pharmacology

Cite this

Current trials of interventions to prevent radiocontrast-induced nephropathy. / Asif, Arif; Garces, Galo; Preston, Richard A; Roth, David.

In: American Journal of Therapeutics, Vol. 12, No. 2, 01.03.2005, p. 127-132.

Research output: Contribution to journalArticle

@article{71a2f04fcae94329a1ec5bd37bcaa363,
title = "Current trials of interventions to prevent radiocontrast-induced nephropathy",
abstract = "Radiocontrast administration is a common cause of hospital-acquired acute renal failure. It is associated with significant in-hospital and long-term morbidity and mortality and increases the costs of medical care by at least extending the hospital stay. A variety of therapeutic interventions, including saline hydration, diuretics, mannitol, calcium channel antagonists, theophylline, endothelin receptor antagonists, and dopamine, have been employed to prevent radiocontrast-induced acute renal failure. Recent advances have examined the impact of fenoldopam (dopamine-1 receptor agonist), N-acetylcysteine (antioxidant), iso-osmolar contrast agents, hemodialysis, and hemofiltration on ameliorating radiocontrast-induced acute renal failure. Although hydration with half-normal saline had remained the gold standard for the prevention of radiocontrast-induced nephropathy, recent data have revealed the superiority of hydration with normal saline over half-normal saline. This review focuses on the most recent studies of interventions to ameliorate radiocontrast-induced acute renal failure and provides a critical analysis of some of the recent studies conducted to prevent radiocontrast-induced nephropathy.",
keywords = "Fenoldopam, Iso-osmolar contrast medium, N-acetylcysteine, Radiocontrast-induced nephropathy, Renal replacement therapy",
author = "Arif Asif and Galo Garces and Preston, {Richard A} and David Roth",
year = "2005",
month = "3",
day = "1",
doi = "10.1097/01.mjt.0000143694.60662.11",
language = "English",
volume = "12",
pages = "127--132",
journal = "American Journal of Therapeutics",
issn = "1075-2765",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Current trials of interventions to prevent radiocontrast-induced nephropathy

AU - Asif, Arif

AU - Garces, Galo

AU - Preston, Richard A

AU - Roth, David

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Radiocontrast administration is a common cause of hospital-acquired acute renal failure. It is associated with significant in-hospital and long-term morbidity and mortality and increases the costs of medical care by at least extending the hospital stay. A variety of therapeutic interventions, including saline hydration, diuretics, mannitol, calcium channel antagonists, theophylline, endothelin receptor antagonists, and dopamine, have been employed to prevent radiocontrast-induced acute renal failure. Recent advances have examined the impact of fenoldopam (dopamine-1 receptor agonist), N-acetylcysteine (antioxidant), iso-osmolar contrast agents, hemodialysis, and hemofiltration on ameliorating radiocontrast-induced acute renal failure. Although hydration with half-normal saline had remained the gold standard for the prevention of radiocontrast-induced nephropathy, recent data have revealed the superiority of hydration with normal saline over half-normal saline. This review focuses on the most recent studies of interventions to ameliorate radiocontrast-induced acute renal failure and provides a critical analysis of some of the recent studies conducted to prevent radiocontrast-induced nephropathy.

AB - Radiocontrast administration is a common cause of hospital-acquired acute renal failure. It is associated with significant in-hospital and long-term morbidity and mortality and increases the costs of medical care by at least extending the hospital stay. A variety of therapeutic interventions, including saline hydration, diuretics, mannitol, calcium channel antagonists, theophylline, endothelin receptor antagonists, and dopamine, have been employed to prevent radiocontrast-induced acute renal failure. Recent advances have examined the impact of fenoldopam (dopamine-1 receptor agonist), N-acetylcysteine (antioxidant), iso-osmolar contrast agents, hemodialysis, and hemofiltration on ameliorating radiocontrast-induced acute renal failure. Although hydration with half-normal saline had remained the gold standard for the prevention of radiocontrast-induced nephropathy, recent data have revealed the superiority of hydration with normal saline over half-normal saline. This review focuses on the most recent studies of interventions to ameliorate radiocontrast-induced acute renal failure and provides a critical analysis of some of the recent studies conducted to prevent radiocontrast-induced nephropathy.

KW - Fenoldopam

KW - Iso-osmolar contrast medium

KW - N-acetylcysteine

KW - Radiocontrast-induced nephropathy

KW - Renal replacement therapy

UR - http://www.scopus.com/inward/record.url?scp=17144383267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144383267&partnerID=8YFLogxK

U2 - 10.1097/01.mjt.0000143694.60662.11

DO - 10.1097/01.mjt.0000143694.60662.11

M3 - Article

C2 - 15767830

AN - SCOPUS:17144383267

VL - 12

SP - 127

EP - 132

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 2

ER -